Ryuichi Okubo
Kagoshima University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ryuichi Okubo.
Journal of the Neurological Sciences | 2006
Fujio Umehara; Hideki Ookatsu; Daisuke Hayashi; Akifumi Uchida; Yukari Douchi; Hisashi Kawabata; Rina Goto; Akihiro Hashiguchi; Eiji Matsuura; Ryuichi Okubo; Itsuro Higuchi; Kimiyoshi Arimura; Yukifumi Nawa; Mitsuhiro Osame
We report serial MR findings in four patients with myelitis caused by visceral larva migrans syndrome due to Toxocara canis or Ascaris suum infection. MR imaging revealed spinal cord swelling with or without gadolinium enhancement in three patients. T2-weighted images showed high signal intensities preferentially located in both lateral and posterior columns. Antihelmintic and corticosteroid treatment yielded improvement in neurologic deficits and spinal lesions. However, one patient with T. canis infection relapsed associated with reappearance of MRI abnormalities.
Neurogenetics | 2004
Ryuki Hirano; Hiroshi Takashima; Ryuichi Okubo; Keiko Tajima; Yuji Okamoto; Shimon Ishida; Kazuhito Tsuruta; Takayo Arisato; Hitoshi Arata; Masanori Nakagawa; Mitsuhiro Osame; Kimiyoshi Arimura
Abstract.The autosomal dominant cerebellar ataxias (ADCAs) are a clinically and genetically heterogeneous group of disorders. To date, at least 11 genes and 13 additional loci have been identified in ADCAs. Despite phenotypic differences, spinocerebellar ataxia 4 (SCA4) and Japanese 16q-linked ADCA type III map to the same region of 16q22.1. We report four Japanese families with pure cerebellar ataxia and a disease locus at 16q22.1. Our families yielded a peak lod score of 6.01 at marker D16S3141. To refine the candidate region, we carried out genetic linkage studies in four pedigrees with a high density set of DNA markers from chromosome 16q22.1. Our linkage data suggest that the disease locus for 16q-ADCA type III is within the 1.25-Mb interval delineated by markers 17msm and CTTT01. We screened for mutations in 36 genes within the critical region. Our critical region lies within the linkage interval reported for SCA4 and for Japanese 16q-ADCA type III. These data suggest that the ADCA that we have characterized is allelic with SCA4 and Japanese 16q-linked ADCA type III.
Journal of Human Genetics | 2009
Ryuki Hirano; Hiroshi Takashima; Ryuichi Okubo; Yuji Okamoto; Yoshimitsu Maki; Shimon Ishida; Masahito Suehara; Youichi Hokezu; Kimiyoshi Arimura
16q-ADCA (OMIM no. 117210) is an autosomal dominant spinocerebellar ataxia (AD-SCA) characterized by late-onset pure cerebellar ataxia and −16C>T substitution of the puratrophin-1 gene. Recently, a series of single-nucleotide polymorphisms (haplotype block) were found to be specific to 16q-ADCA. We screened patients with ataxia and found 62 patients, including four homozygotes who carry the C–T substitution of the puratrophin-1 gene. By further analysis of the patients with the haplotype block, we observed a single-founder effect for 16q-ADCA, even in patients who are supposed to be sporadic late cortical cerebellar atrophy (LCCA). We also observed slippage mutations of microsatellite markers, GATA01 and 17msm, in the pedigrees. We compared the clinical course of 16q-ADCA in heterozygotes and homozygotes with the haplotype block and observed no apparent gene dosage effect. 16q-ADCA accounts for 27% of AD-SCAs and is the most frequent AD-SCA in South Kyushu, Japan.
Neurology | 2006
Fujio Umehara; N. Tokunaga; Y. Hokezu; E. Hokonohara; K. Yoshishige; T. Shiraishi; Ryuichi Okubo; Mitsuhiro Osame
Human T lymphotropic virus type I (HTLV-I) is associated with adult T cell leukemia (ATL) and a chronic progressive disease of the CNS termed HTLV-I–associated myelopathy (HAM)/tropical spastic paraparesis (TSP).1,2 The most common MRI findings of HAM/TSP are spinal cord atrophy predominantly involving the thoracic cord levels. In this article, we report two patients with HAM/TSP, who developed transient cervical cord lesions on MRI during the course of the illness. Patient 1 is 39-year-old woman who developed progressive gait and urinary disturbance when she was 22 years old. At age 35, she was diagnosed with HAM/TSP. MRI taken at age 37 showed spinal cord atrophy predominantly in the thoracic region (see figure E-1 on the Neurology Web site at www.neurology.org). Despite various treatments, her symptoms gradually worsened. At age 39, she noticed numbness and pain in the right upper limbs. On neurologic examination, muscle strength in the lower limbs was moderately decreased. Deep tendon reflexes were mildly exaggerated in the upper limbs and highly exaggerated in …
Neuromuscular Disorders | 1995
Itsuro Higuchi; Hidetoshi Fukunaga; Kiichiro Matsumura; Masaru Inose; Kotaro Izumi; Ryuichi Okubo; Masanori Nakagawa; Teruo Shimizu; Mitsuhiro Osame
We recently reported the selective reduction of the B1 subunit of laminin in two Japanese patients with adhalin deficiency. We here investigated immunohistochemically the expression of other components of the extracellular matrix (ECM), including collagen type IV, heparan sulfate proteoglycan can (HSPG), chondroitin-4-sulfate proteoglycan, decorin, and fibronectin in adhalin deficiency, compared with other types of muscular dystrophy. We found a reduction of HSPG on the basal lamina surrounding each muscle fiber in adhalin deficiency compared with HSPG in other diseases. This finding may be characteristic evidence of the disturbance of the sarcolemma-ECM interaction and the sarcolemmal instability in adhalin deficiency. Recently, a direct role of HSPG in fibroblast growth factor (FGF) signal transduction was demonstrated. Further investigation is required to determine if the dysfunction of FGF is relevant to the pathogenesis of adhalin deficiency.
Neuromuscular Disorders | 2012
Yukie Inamori; Itsuro Higuchi; Teruhiko Inoue; Yusuke Sakiyama; Akihiro Hashiguchi; Keiko Higashi; Tadafumi Shiraishi; Ryuichi Okubo; Kimiyoshi Arimura; Yoshio Mitsuyama; Hiroshi Takashima
Inclusion body myositis is an inflammatory myopathy characterized pathologically by rimmed vacuoles and the accumulation of amyloid-related proteins. Autopsy studies in these patients, including histochemical examinations of multiple skeletal muscles, have not yet been published. In this paper, we describe the autopsy findings of a patient with inclusion body myositis and hypertrophic cardiomyopathy. A 69-year-old man, who was a human T lymphotropic virus type 1 carrier, exhibited slowly progressive muscle weakness and atrophy, predominantly affecting the scapular, quadriceps femoris, and forearm flexor muscles. His disease course was more rapidly progressive than that typically observed; the patient died suddenly of arrhythmia 5 years after diagnosis. Autopsy findings revealed that multiple muscles, including the respiratory muscles, were involved. Longitudinal studies revealed an increased frequency of rimmed vacuoles and p62/sequestosome 1- and/or TAR DNA-binding protein 43-positive deposits in autopsied muscles, although the amount of inflammatory infiltrate appeared to be decreased. We speculated that muscle degeneration may be more closely involved in disease progression compared with autoimmunity. Genetic analysis revealed a myosin binding protein C3 mutation, which is reportedly responsible for familial hypertrophic cardiomyopathy. This mutation and human T lymphotropic virus type 1 infection may have affected the skeletal muscles of this patient.
Neuroimmunology and Neuroinflammation | 2015
Yusuke Sakiyama; Naoaki Kanda; Yujiro Higuchi; Michiyoshi Yoshimura; Hiroyuki Wakaguri; Yoshiharu Takata; Osamu Watanabe; Junhui Yuan; Yuichi Tashiro; Ryuji Saigo; Satoshi Nozuma; Akiko Yoshimura; Shiho Arishima; Kenichi Ikeda; Kazuya Shinohara; Hitoshi Arata; Kumiko Michizono; Keiko Higashi; Akihiro Hashiguchi; Yuji Okamoto; Ryuki Hirano; Tadafumi Shiraishi; Eiji Matsuura; Ryuichi Okubo; Itsuro Higuchi; Masamichi Goto; Hirofumi Hirano; Akira Sano; Takuya Iwasaki; Fumihiko Matsuda
Objective: To determine the causative pathogen and investigate the effective treatment of a new type of encephalomyelitis with an unknown pathogen in Japan and report the preliminary ultrastructural and genomic characterization of the causative agent. Methods: From 2005 to 2012, we treated 4 Japanese patients with geographic clustering and comparable clinical features, serum/CSF cytology, and radiologic findings. Brain biopsy was conducted in all patients to analyze neuropathologic changes by histology, and electron microscopy was applied to reveal the features of the putative pathogen. Genomic DNA was obtained from the affected brain tissues and CSF, and an unbiased high-throughput sequencing approach was used to screen for specific genomic sequences indicative of the pathogen origin. Results: All patients exhibited progressive dementia with involuntary tongue movements. Cytologic examination of CSF revealed elevated mononuclear cells. Abnormal MRI signals were observed in temporal lobes, subcortical white matter, and spinal cord. Biopsied brain tissue exhibited aggregated periodic acid-Schiff–positive macrophages and 2–7 μm diameter round/oval bodies without nuclei or cell walls scattered around the vessels. Unbiased high-throughput sequencing identified more than 100 archaea-specific DNA fragments. All patients were responsive to trimethoprim/sulfamethoxazole (TMP-SMX) plus corticosteroid therapy. Conclusions: We report 4 cases of encephalomyelitis due to an unknown pathogen. On the basis of ultrastructural and genomic studies, we propose a new disease entity resulting from a causative pathogen having archaeal features. TMP-SMX therapy was effective against this new type of encephalomyelitis.
Journal of the Neurological Sciences | 2018
Michiyoshi Yoshimura; Junhui Yuan; Keiko Higashi; Akiko Yoshimura; Hitoshi Arata; Ryuichi Okubo; Yoshiaki Nakabeppu; Takashi Yoshiura; Hiroshi Takashima
BACKGROUND AND PURPOSE Gerstmann-Sträussler-Scheinker syndrome is a rare hereditary neurodegenerative disorder with clinical heterogeneity. This study is aim to demonstrate the clinical spectrum and radiologic characteristics of patients caused by Pro102Leu mutation in PRNP. MATERIALS AND METHODS We retrospect clinical manifestations of five patients from four Japanese families, and comprehensively analyzed their brain MRI, SPECT (N-isopropyl-p-[123I] iodoamphetamine), and PET (18F-2-fluoro-2-deoxy-d-glucose) images. RESULTS All patients developed ataxia of lower limbs and trunk, gait disturbance, dysesthesia in legs, and lower limb hyporeflexia. In the early clinical stage before dementia began, no noticeable abnormalities could be observed from brain MRI, but SPECT and PET revealed mosaic-like pattern of blood flow and glucose metabolism of the brain. Predominant abnormalities were found in the occipital and frontal lobes on SPECT and PET analysis, respectively. In SPECT analysis, blood flow of the anterior cerebellar lobes was lower than that of the posterior cerebellar lobes. CONCLUSIONS Clinical symptoms resulting from failure of dorsal horn of spinal cord and spinocerebellar tracts were observed in all cases. Radiologic findings revealed individual differences of involved region in their brain, which could produce clinical diversity. We identified a downtrend of blood flow in the anterior cerebellar lobes, a projection field of the spinocerebellar tracts, which is an important feature of Gerstmann-Sträussler-Scheinker syndrome.
Acta Neuropathologica | 2003
Takayo Arisato; Ryuichi Okubo; Hitoshi Arata; Koji Abe; Kei Fukada; Saburo Sakoda; Akira Shimizu; Xing Hui Qin; Shuji Izumo; Mitsuhiro Osame; Masanori Nakagawa
Journal of Epidemiology | 2000
Hiroshi Shimokata; Yoshiji Yamada; Masanori Nakagawa; Ryuichi Okubo; Takaomi C. Saido; Akihiro Funakoshi; Kyoko Miyasaka; Shigeo Ohta; Gozoh Tsujimoto; Masashi Tanaka; Fujiko Ando; Naoakira Niino